These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30196823)

  • 1. Genome-wide association study in Guillain-Barré syndrome.
    Blum S; Ji Y; Pennisi D; Li Z; Leo P; McCombe P; Brown MA
    J Neuroimmunol; 2018 Oct; 323():109-114. PubMed ID: 30196823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
    Kuijf ML; Geleijns K; Ennaji N; van Rijs W; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2008 Dec; 205(1-2):110-2. PubMed ID: 18838176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
    Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
    Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
    Geleijns K; Schreuder GM; Jacobs BC; Sintnicolaas K; van Koningsveld R; Meulstee J; Laman JD; van Doorn PA
    Neurology; 2005 Jan; 64(1):44-9. PubMed ID: 15642902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-DR/DQ polymorphisms with Guillain-Barré syndrome in Tunisian patients.
    Fekih-Mrissa N; Mrad M; Riahi A; Sayeh A; Zaouali J; Gritli N; Mrissa R
    Clin Neurol Neurosurg; 2014 Jun; 121():19-22. PubMed ID: 24793468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh.
    Jahan I; Ahammad RU; Farzana KS; Khalid MM; Islam MB; Rahman MI; Nahar S; Kabir Y; Mohmmad QD; Islam Z
    J Neuroimmunol; 2017 Sep; 310():46-50. PubMed ID: 28778444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome.
    Hayat S; Jahan I; Das A; Hassan Z; Howlader ZH; Mahmud I; Deen Mohammad Q; Islam Z
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1849-1857. PubMed ID: 31469245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barré syndrome.
    Liu H; Xing Y; Guo Y; Liu P; Zhang H; Xue B; Shou J; Qian J; Peng J; Wang R; Gao Y; Fang S
    J Neurol Sci; 2016 Oct; 369():39-42. PubMed ID: 27653862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
    Dekker MJ; van den Akker EL; Koper JW; Manenschijn L; Geleijns K; Ruts L; van Rijs W; Tio-Gillen AP; van Doorn PA; Lamberts SW; Jacobs BC
    J Peripher Nerv Syst; 2009 Jun; 14(2):75-83. PubMed ID: 19691529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population.
    Dourado ME; Ferreira LC; Freire-Neto FP; Jeronimo SM
    J Neuroimmunol; 2016 Sep; 298():160-4. PubMed ID: 27609290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
    Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
    J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
    Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
    J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population.
    Rahman MI; Jahan I; Khalid MM; Jahan I; Ahammad RU; Nahar S; Islam Z
    J Neuroimmunol; 2018 Jan; 314():8-12. PubMed ID: 29301656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence of Guillain-Barre syndrome within families.
    Geleijns K; Brouwer BA; Jacobs BC; Houwing-Duistermaat JJ; van Duijn CM; van Doorn PA
    Neurology; 2004 Nov; 63(9):1747-50. PubMed ID: 15534275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.
    Schirmer L; Worthington V; Solloch U; Loleit V; Grummel V; Lakdawala N; Grant D; Wassmuth R; Schmidt AH; Gebhardt F; Andlauer TF; Sauter J; Berthele A; Lunn MP; Hemmer B
    J Neurol; 2016 Oct; 263(10):2105-13. PubMed ID: 27485170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1.
    Jaramillo-Valverde L; Levano KS; Villanueva I; Hidalgo M; Cornejo M; Mazzetti P; Cornejo-Olivas M; Sanchez C; Poterico JA; Valdivia-Silva J; Guio H
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00960. PubMed ID: 31464097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis.
    Jin PP; Sun LL; Ding BJ; Qin N; Zhou B; Xia F; Li L; Liu LJ; Liu XD; Zhao G; Wang W; Deng YC; Hou SX
    PLoS One; 2015; 10(7):e0131374. PubMed ID: 26204120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
    Kharwar NK; Prasad KN; Paliwal VK; Modi DR
    J Neurol Sci; 2016 Apr; 363():57-62. PubMed ID: 27000222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 pathway signatures in a large Indian cohort of Guillain Barré syndrome.
    Debnath M; Nagappa M; Subbanna M; Sundaravadivel P; Talukdar PM; Shivakumar V; Wahatule R; Dutta D; Binukumar B; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Taly AB
    J Neuroimmunol; 2018 Oct; 323():125-130. PubMed ID: 30196825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.